Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers

PLoS One. 2013;8(3):e59368. doi: 10.1371/journal.pone.0059368. Epub 2013 Mar 15.

Abstract

Background: Sepsis induces early activation of coagulation and fibrinolysis followed by late fibrinolytic shutdown and progressive endothelial damage. The aim of the present study was to investigate and compare the functional hemostatic response in whole blood and plasma during experimental human endotoxemia by the platelet function analyzer, Multiplate and by standard and modified thrombelastography (TEG).

Methods: Prospective physiologic study of nine healthy male volunteers undergoing endotoxemia by means of a 4-hour infusion of E. coli lipopolysaccharide (LPS, 0.5 ng/kg/hour), with blood sampled at baseline and at 4 h and 6 h. Physiological and standard biochemical data and coagulation tests, TEG (whole blood: TEG, heparinase-TEG, Functional Fibrinogen; plasma: TEG±tissue-type plasminogen activator (tPA)) and Multiplate (TRAPtest, ADPtest, ASPItest, COLtest) were recorded. Mixed models with Tukey post hoc tests and correlations were applied.

Results: Endotoxemia induced acute SIRS with increased HR, temperature, WBC, CRP and procalcitonin and decreased blood pressure. It also induced a hemostatic response with platelet consumption and reduced APTT while INR increased (all p<0.05). Platelet aggregation decreased (all tests, p<0.05), whereas TEG whole blood clot firmness increased (G, p = 0.05). Furthermore, during endotoxemia (4 h), whole blood fibrinolysis increased (clot lysis time (CLT), p<0.001) and Functional Fibrinogen clot strength decreased (p = 0.049). After endotoxemia (6 h), whole blood fibrinolysis was reduced (CLT, p<0.05). In contrast to findings in whole blood, the plasma fibrin clot became progressively more resistant towards tPA-induced fibrinolysis at both 4 h and 6 h (p<0.001).

Conclusions: Endotoxemia induced a hemostatic response with reduced primary but enhanced secondary hemostasis, enhanced early fibrinolysis and fibrinogen consumption followed by downregulation of fibrinolysis, with a discrepant fibrinolytic response in plasma and whole blood. The finding that blood cells are critically involved in the vasculo-fibrinolytic response to acute inflammation is important given that disturbances in the vascular system contribute significantly to morbidity and mortality in critically ill patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Coagulation*
  • Blood Platelets / metabolism*
  • Blood Platelets / pathology
  • Blood Pressure
  • Calcitonin / blood
  • Calcitonin Gene-Related Peptide
  • Endotoxemia / blood*
  • Endotoxemia / chemically induced
  • Endotoxemia / pathology
  • Erythrocytes / metabolism*
  • Erythrocytes / pathology
  • Fibrinogen / metabolism
  • Humans
  • Lipopolysaccharides
  • Male
  • Partial Thromboplastin Time
  • Platelet Aggregation
  • Prospective Studies
  • Protein Precursors / blood
  • Thrombelastography
  • Tissue Plasminogen Activator / blood
  • Whole Blood Coagulation Time
  • Young Adult

Substances

  • CALCA protein, human
  • Lipopolysaccharides
  • Protein Precursors
  • Fibrinogen
  • Calcitonin
  • Tissue Plasminogen Activator
  • Calcitonin Gene-Related Peptide

Grants and funding

The study was supported by The Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich, The Foundation of 1870, The Toyota Foundation, Christian Larsen and Judge Ella Larsen’s grant, The Classen Trust Jubilee Foundation, The P. Carl Petersen Foundation, University Hospital Rigshospitalet, and the Faculty of Health Sciences, University of Copenhagen. The study was further supported by the Danish Council for Independent Research – Medical Sciences, the Commission of the European Communities (grant agreement number 223576 – MYOAGE). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 – the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant number 09-067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.